VEGFA and retinopathy of prematurity: At the meanwhile, we have explored a lower dose of anti-VEGF drug intravitreal injection for ROP to reduce the possible systemic adverse reactions (published in Chinese, http://www.coretina.com/article/10.3760/cma.j.cn511434-20200219-00066).